| Office, Research |
NCT03942419: Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression |
|
|
| Recruiting | 3 | 420 | US | Atropine 0.1% Ophthalmic Solution, Atropine 0.01% Ophthalmic Solution, Placebo Ophthalmic Solution | Eyenovia Inc. | Myopia | 06/28 | 06/28 | | |
| Recruiting | 2 | 120 | Europe | Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol | Prof. Janet Dunn, Blood Cancer UK, Dudley Group NHS Foundation Trust, University of Birmingham, University of Manchester, King's College Hospital NHS Trust | Myelodysplastic Syndromes (MDS) | 01/25 | 06/25 | | |
NCT06166056: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis |
|
|
| Recruiting | 1/2 | 45 | Europe | CHF6333, CHF6333 Placebo | Chiesi Farmaceutici S.p.A. | Bronchiectasis | 06/25 | 06/25 | | |
KEYNOTE-D88, NCT05572684: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors |
|
|
| Recruiting | 1/2 | 131 | US | NC410, pembrolizumab, KEYTRUDA® | NextCure, Inc., Merck Sharp & Dohme LLC | Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High, Microsatellite Stable, Ovarian Cancer, Gastric Cancer, Colo-rectal Cancer, Esophageal Cancer, Endometrial Cancer, Head Neck Cancer, Cervical Cancer, Lung Cancer | 07/25 | 11/25 | | |
| Not yet recruiting | N/A | 60 | Europe | Enriched Music-Supported Therapy, Music-Supported Therapy, Graded Repetitive Arm Supplementary Program, GRASP | University of Barcelona, Artificial Intelligence Research Institute, Spanish National Research Council, University of Helsinki | Stroke | 07/21 | 07/22 | | |
Geospatial, NCT05076539: A Quantitative Assessment of Early Mobility in Total Knee Replacement Patients Using Smart Activity Tracker |
|
|
| Recruiting | N/A | 50 | RoW | Garmin GPS activity tracker | Singapore General Hospital, Curtin University | Knee Osteoarthritis | 10/22 | 01/23 | | |
| Recruiting | N/A | 300 | Europe | Neurothesiometer, NERVE | University Hospitals Dorset NHS Foundation Trust | Diabetic Foot | 04/24 | 04/24 | | |
NCT04941924: The ID- RFA Trial: A Trial of Intraductal Radio-frequency Ablation (ID-RFA) Plus Biliary Stenting Versus Biliary Stenting Alone for the Treatment of Malignant Biliary Obstruction. |
|
|
| Recruiting | N/A | 24 | Europe | Intraductal Radio-Frequency Ablation, Biliary Stent Placement | University Hospitals Dorset NHS Foundation Trust, The Christie NHS Foundation Trust | Malignant Biliary Obstruction | 10/23 | 10/23 | | |
| Withdrawn | N/A | 37 | Europe | SBRT followed by surgical stabilization within 24-48 hours | UMC Utrecht | Spinal Neoplasms, Neoplasm Metastasis, Radiosurgery, Surgery | 10/23 | 11/23 | | |
NCT03348995: The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration |
|
|
| Active, not recruiting | N/A | 250 | US | Bridge-Enhanced ACL Restoration (BEAR) | Miach Orthopaedics | Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Rupture | 04/24 | 04/34 | | |
| Recruiting | N/A | 1000 | US, RoW | MarginProbe2.0, MP2.0 | Dilon Medical Technologies Ltd. | Breast Cancer | 10/24 | 12/24 | | |
NCT00898313: Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer |
|
|
| Recruiting | N/A | 4000 | US | comparative genomic hybridization, gene expression microarray analysis, proteomic profiling analysis, biologic sample preservation procedure, nasal brushing, Blood draw, Urine collection, sputum sample, fluorescence bronchoscopy with airway biopsy, fine needle aspiration of the lung, thoracentesis | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Lung Cancer | 01/25 | 01/25 | | |
| Arora, Garima |
| Active, not recruiting | N/A | 96 | Canada | | Horizon Health Network | Multiple Myeloma | 12/24 | 03/26 | | |
